Evidence map›Paper›PMID 26660560›Full record

ArticlePhysiological reports2015

Cigarette smoke represses the innate immune response to asbestos.

Gilbert F Morris, Svitlana Danchuk, Yu Wang, Beibei Xu, Roy J Rando, Arnold R Brody, Bin Shan, Deborah E Sullivan

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Asbestos, Smoking and Lung Cancer: An Update.International journal of environmental research and public health · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Gilbert F MorrisDepartments of Pathology and Laboratory Medicine, Program in Lung Biology, New Orleans, Louisiana gmorris2@tulane.edu.
Svitlana DanchukMicrobiology and Immunology, Program in Lung Biology, New Orleans, Louisiana.
Yu WangDepartments of Pathology and Laboratory Medicine, Program in Lung Biology, New Orleans, Louisiana.
Beibei XuDepartments of Pathology and Laboratory Medicine, Program in Lung Biology, New Orleans, Louisiana.
Roy J RandoGlobal Environmental Health Sciences, Tulane University Health Sciences Center Program in Lung Biology, New Orleans, Louisiana.
Arnold R BrodyDepartments of Pathology and Laboratory Medicine, Program in Lung Biology, New Orleans, Louisiana.
Bin ShanCollege of Medical Sciences, Washington State University Spokane Program in Lung Biology, Spokane, Washington.
Deborah E SullivanMicrobiology and Immunology, Program in Lung Biology, New Orleans, Louisiana.
University Medical Center New Orleans · USTulane University · USWashington State University Spokane · US

Funding

Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette SmokeR01CA132603 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI MORRIS, GILBERT F, SHAN, BIN · 2008 to 2012
$1.8M
NCI NIH HHS R01 CA132603
6 · The paper itself

Abstract

Both cigarette smoke (CS) and asbestos cause lung inflammation and lung cancer, and at high asbestos exposure levels, populations exposed to both of these carcinogens display a synergistic increase in the development of lung cancer. The mechanisms through which these two toxic agents interact to promote lung tumorigenesis are poorly understood. Here, we begin to dissect the inflammatory signals induced by asbestos in combination with CS using a rodent inhalation model and in vitro cell culture. Wild-type C57BL/6 mice were exposed to room air as a control, CS, and/or asbestos (4 days per week to CS and 1 day per week to asbestos for 5 weeks). Bronchoalveolar lavage (BAL) fluid was collected following exposure and analyzed for inflammatory mediators. Asbestos-exposed mice displayed an increased innate immune response consistent with NLRP3 inflammasome activation. Compared to mice exposed only to asbestos, animals coexposed to CS + asbestos displayed attenuated levels of innate immune mediators and altered inflammatory cell recruitment. Histopathological changes in CS + asbestos-exposed mice correlated with attenuated fibroproliferative lesion development relative to their counterparts exposed only to asbestos. In vitro experiments using a human monocyte cell line (THP-1 cells) supported the in vivo results in that coexposure to cigarette smoke extract repressed NLRP3 inflammasome markers in cells treated with asbestos. These observations indicate that CS represses central components of the innate immune response to inhaled asbestos.

Indexed as

Asbestoscigarette smokeIL‐18IL‐1βNLRP3 inflammasome

Identifiers

PMID26660560
PMCPMC4760433
OpenAlexW2253492555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.